Abdallah M. Ibrahim: Evolving Hemophilia Care – How Do We Choose the Right Biomarkers?
Abdallah M. Ibrahim, Senior Medical Student at Alexandria University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in ASIDE, adding:
“Glad to share another research publication that our narrative review, ‘Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility,’ has been published in American Society for Inclusion, Diversity, and Equity in Healthcare (ASIDE) Internal medicine (Vol. 2, No. 5, 2026).
Hemophilia care is evolving fast:
Extended half-life therapies, non-factor treatments, and gene therapy are changing what’s possible, but that progress raises a real question: how do we select the right biomarkers to guide diagnosis, risk stratification, and treatment choice?
Our review synthesized the literature from 2000 to 2025, covering established tools (FVIII/FIX activity assays, inhibitor testing, genotyping, imaging-based joint assessment) alongside emerging candidates like global hemostasis assays and inflammatory biomarkers linked to joint disease.
The conclusion is honest: evidence in this space is still heterogeneous, and most non-traditional markers remain exploratory pending standardized, multicenter validation.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question